SAB Biotherapeutics (SABS) Shares Outstanding (Entity) (2020 - 2026)
SAB Biotherapeutics (SABS) posted Shares Outstanding (Entity) of 83.49 million for Q2 2026, up 798.6% from 9.29 million a year earlier and up 55.9% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
For FY2025, SAB Biotherapeutics' Shares Outstanding (Entity) came in at 19.31 million, up 107.9% from FY2024.
- Annual Shares Outstanding (Entity) has increased for five consecutive years, with a five-year compound annual growth rate of 50.0% (FY2020 to FY2025).
- In prior years, SAB Biotherapeutics' Shares Outstanding (Entity) was 9.29 million in FY2024 (+68.2%), 5.52 million in FY2023 (+9.6%), 5.04 million in FY2022 (+84.3%) and 2.73 million in FY2021 (+7.7%).
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) in data going back to Q4 2020.
- On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last 17 quarters, with growth averaging 193.0% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Entity) has ranged between 0.7% (Q1 2025) and 820.5% (Q2 2022) over the last five years.
- According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 53.56 million (Q1 2026), 19.31 million (Q4 2025) and 10.66 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | SAB Biotherapeutics | 264.67 Mn | 264.67 Mn | - | 83.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 83.49 Mn |
| Mar 31, 2026 | 53.56 Mn |
| Dec 31, 2025 | 19.31 Mn |
| Sep 30, 2025 | 10.66 Mn |
| Jun 30, 2025 | 9.29 Mn |
| Mar 31, 2025 | 9.29 Mn |
| Dec 31, 2024 | 9.29 Mn |
| Sep 30, 2024 | 9.23 Mn |
| Jun 30, 2024 | 9.23 Mn |
| Mar 31, 2024 | 9.23 Mn |
| Dec 31, 2023 | 5.52 Mn |
| Sep 30, 2023 | 5.23 Mn |
| Jun 30, 2023 | 5.23 Mn |
| Mar 31, 2023 | 5.09 Mn |
| Dec 31, 2022 | 5.04 Mn |
| Sep 30, 2022 | 4.30 Mn |
| Jun 30, 2022 | 4.30 Mn |
| Mar 31, 2022 | 4.30 Mn |
| Dec 31, 2021 | 2.73 Mn |
| Sep 30, 2021 | 1.48 Mn |
API Access
SAB Biotherapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();